Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Utilizing marine sources to extract DHA to treat Alzheimer’s

Utilizing marine sources to extract DHA to treat Alzheimer’s

The brain's claustrum behaves more like a high-speed internet router, research finds

The brain's claustrum behaves more like a high-speed internet router, research finds

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

How air pollution affects the central nervous system over time

How air pollution affects the central nervous system over time

People with Alzheimer's disease can be identified before any symptoms appear

People with Alzheimer's disease can be identified before any symptoms appear

Study shows biological link between muscle weakness and acceleration in biological age

Study shows biological link between muscle weakness and acceleration in biological age

The roles of innate and adaptive immunity in Alzheimer’s disease development and progression

The roles of innate and adaptive immunity in Alzheimer’s disease development and progression

Characteristics of patients' drawing process can determine the type of dementia, study finds

Characteristics of patients' drawing process can determine the type of dementia, study finds

New biomarker could aid in early diagnosis of Alzheimer’s disease

New biomarker could aid in early diagnosis of Alzheimer’s disease

Researchers find an innovative approach to improve waste clearance from the brain

Researchers find an innovative approach to improve waste clearance from the brain

Researchers use lasso-grafting for designing receptor agonists with enhanced pharmacokinetics

Researchers use lasso-grafting for designing receptor agonists with enhanced pharmacokinetics

UQ researchers discover a link between obstructive sleep apnea and dementia

UQ researchers discover a link between obstructive sleep apnea and dementia

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

Beer hop compounds could serve as the basis for nutraceuticals to combat Alzheimer’s disease

Beer hop compounds could serve as the basis for nutraceuticals to combat Alzheimer’s disease

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

Experts estimate the prevalence of breast cancer survivors in Canada

Experts estimate the prevalence of breast cancer survivors in Canada

Moderate to heavy drinking could increase the risk of stroke in young adults

Moderate to heavy drinking could increase the risk of stroke in young adults

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs